Nuclear hormone receptor expression in mouse kidney and renal cell lines

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Ogawa, Daisuke ^a   Eguchi, Jun ^a   Wada, Jun ^a   Terami, Naoto ^a   Hatanaka, Takashi ^a   Tachibana, Hiromi ^a   Nakatsuka, Atsuko ^a   Horiguchi, Chikage Sato ^a   Nishii, Naoko ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 3; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; LIVER X RECEPTOR ALPHA; NEURON DERIVED CLONE 77; NUCLEAR HORMONE RECEPTOR; NUCLEAR RECEPTOR NR4A3; NUCLEAR RECEPTOR RELATED FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CELL RECEPTOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; NR2F6 PROTEIN, MOUSE; NR4A1 PROTEIN, MOUSE; NUCLEAR RECEPTOR NUR77;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HYPERGLYCEMIA; KIDNEY COLLECTING TUBULE; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; MALE; MESANGIUM CELL; METABOLIC REGULATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; CLASSIFICATION; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; KIDNEY; KIDNEY TUBULE; METABOLISM; MUTANT MOUSE STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CELLS, CULTURED; COUP TRANSCRIPTION FACTOR II; COUP TRANSCRIPTION FACTORS; DIABETIC NEPHROPATHIES; GENE EXPRESSION; KIDNEY; KIDNEY TUBULES; MALE; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROSCOPY, FLUORESCENCE; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PODOCYTES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84899791728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085594     Document Type: Article

References (45)

1. Susztak K, Bottinger EP (2006) Diabetic nephropathy: a frontier for personalized medicine. J Am Soc Nephrol 17: 361-367.
2. Kanwar YS, Sun L, Xie P, Liu FY, Chen S (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6: 395-423.
3. Libby P, Plutzky J (2007) Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Am J Cardiol 99: 27B-40B.
4. Yang J, Zhou Y, Guan Y (2012) PPARgamma as a therapeutic target in diabetic nephropathy and other renal diseases. Curr Opin Nephrol Hypertens 21: 97-105.
5. Pistrosch F, Passauer J, Herbrig K, Schwanebeck U, Gross P, et al. (2012) Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy. Horm Metab Res 44: 914-918.
6. Ansquer JC, Foucher C, Aubonnet P, Le Malicot K (2009) Fibrates and microvascular complications in diabetes-insight from the FIELD study. Curr Pharm Des 15: 537-552.
7. Wang Y, Deb DK, Zhang Z, Sun T, Liu W, et al. (2012) Vitamin D receptor signaling in podocytes protects against diabetic nephropathy. J Am Soc Nephrol 23: 1977-1986.
8. Sanchez-Nino MD, Bozic M, Cordoba-Lanus E, Valcheva P, Gracia O, et al. (2012) Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Am J Physiol Renal Physiol 302: F647-657.
9. Wang XX, Jiang T, Shen Y, Adorini L, Pruzanski M, et al. (2009) The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am J Physiol Renal Physiol 297: F1587-1596.
10. Catanuto P, Doublier S, Lupia E, Fornoni A, Berho M, et al. (2009) 17 betaestradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int 75: 1194-1201.
11. Matsushita Y, Ogawa D, Wada J, Yamamoto N, Shikata K, et al. (2011) Activation of peroxisome proliferator-activated receptor delta inhibits strepto-zotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice. Diabetes 60: 960-968.
12. Tachibana H, Ogawa D, Matsushita Y, Bruemmer D, Wada J, et al. (2012) Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy. J Am Soc Nephrol 23: 1835-1846.
13. Niehof M, Borlak J (2008) HNF4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy. Diabetes 57: 1069-1077.
14. Giguere V (2008) Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 29: 677-696.
15. Fu M, Sun T, Bookout AL, Downes M, Yu RT, et al. (2005) A Nuclear Receptor Atlas: 3T3-L1 adipogenesis. Mol Endocrinol 19: 2437-2450. (Pubitemid 41362659)
16. Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, et al. (2005) A Nuclear Receptor Atlas: macrophage activation. Mol Endocrinol 19: 2466-2477. (Pubitemid 41362661)
17. Chuang JC, Cha JY, Garmey JC, Mirmira RG, Repa JJ (2008) Research resource: nuclear hormone receptor expression in the endocrine pancreas. Mol Endocrinol 22: 2353-2363.
18. Kitamura S, Maeshima Y, Sugaya T, Sugiyama H, Yamasaki Y, et al. (2003) Transforming growth factor-beta 1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells. Nephron Exp Nephrol 95: e79-86.
19. Okada T, Wada J, Hida K, Eguchi J, Hashimoto I, et al. (2006) Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms. Diabetes 55: 1666-1677. (Pubitemid 44324119)
20. Yasuhara A, Wada J, Malakauskas SM, Zhang Y, Eguchi J, et al. (2008) Collectrin is involved in the development of salt-sensitive hypertension by facilitating the membrane trafficking of apical membrane proteins via interaction with soluble N-ethylmaleiamide-sensitive factor attachment protein receptor complex. Circulation 118: 2146-2155.
21. Ogawa D, Asanuma M, Miyazaki I, Tachibana H, Wada J, et al. (2011) High glucose increases metallothionein expression in renal proximal tubular epithelial cells. Exp Diabetes Res 2011: 534872.
22. (1999) A unified nomenclature system for the nuclear receptor superfamily. Cell 97: 161-163.
23. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
24. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, et al. (2006) Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126: 789-799. (Pubitemid 44233630)
25. Dwyer MA, Kazmin D, Hu P, McDonnell DP, Malek G (2011) Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration. Mol Endocrinol 25: 360-372.
26. Yang X, Downes M, Yu RT, Bookout AL, He W, et al. (2006) Nuclear receptor expression links the circadian clock to metabolism. Cell 126: 801-810. (Pubitemid 44233631)
27. Wang XX, Jiang T, Levi M (2010) Nuclear hormone receptors in diabetic nephropathy. Nat Rev Nephrol 6: 342-351.
28. Suh JM, Yu CT, Tang K, Tanaka T, Kodama T, et al. (2006) The expression profiles of nuclear receptors in the developing and adult kidney. Mol Endocrinol 20: 3412-3420. (Pubitemid 44833580)
29. Yu CT, Tang K, Suh JM, Jiang R, Tsai SY, et al. (2012) COUP-TFII is essential for metanephric mesenchyme formation and kidney precursor cell survival. Development 139: 2330-2339.
30. Park CW, Kim HW, Ko SH, Chung HW, Lim SW, et al. (2006) Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha. Diabetes 55: 885-893.
31. Park CW, Zhang Y, Zhang X, Wu J, Chen L, et al. (2006) PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Kidney Int 69: 1511-1517.
32. Wu J, Zhang Y, Wang N, Davis L, Yang G, et al. (2004) Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells. Am J Physiol Renal Physiol 287: F886-895. (Pubitemid 39391085)
33. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, et al. (2006) Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55: 2502-2509. (Pubitemid 44871150)
34. Tanaka Y, Kume S, Araki S, Isshiki K, Chin-Kanasaki M, et al. (2011) Fenofibrate, a PPARalpha agonist, has renoprotective effects in mice by enhancing renal lipolysis. Kidney Int 79: 871-882.
35. Sonoda J, Laganiere J, Mehl IR, Barish GD, Chong LW, et al. (2007) Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gammainduced host defense. Genes Dev 21: 1909-1920. (Pubitemid 47204930)
36. Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, et al. (2007) Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab 5: 345-356. (Pubitemid 46667756)
37. Teng CT, Li Y, Stockton P, Foley J (2011) Fasting induces the expression of PGC-1alpha and ERR isoforms in the outer stripe of the outer medulla (OSOM) of the mouse kidney. PLoS One 6: e26961.
38. Tremblay AM, Dufour CR, Ghahremani M, Reudelhuber TL, Giguere V (2010) Physiological genomics identifies estrogen-related receptor alpha as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway. Mol Endocrinol 24: 22-32.
39. Alaynick WA, Way JM, Wilson SA, Benson WG, Pei L, et al. (2010) ERRgamma regulates cardiac, gastric, and renal potassium homeostasis. Mol Endocrinol 24: 299-309.
40. Wang L, Li Y, Hu P, Teng CT (2008) PGC-1alpha induces dynamic protein interactions on the ERRalpha gene multi-hormone response element nucleosome in kidney cells. Biochem J 416: 407-419.
41. Pearen MA, Muscat GE (2010) Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol 24: 1891-1903.
42. Pirih FQ, Aghaloo TL, Bezouglaia O, Nervina JM, Tetradis S (2005) Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo. Biochem Biophys Res Commun 332: 494-503. (Pubitemid 40725004)
43. Ji R, Sanchez CM, Chou CL, Chen XB, Woodward DF, et al. (2012) Prostanoid EP(1) receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-kappaB. Br J Pharmacol 166: 1033-1046.
44. Levi M (2011) Nuclear receptors in renal disease. Biochim Biophys Acta 1812: 1061-1067.
45. Wang XX, Jiang T, Shen Y, Santamaria H, Solis N, et al. (2011) Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism. Am J Physiol Renal Physiol 300: F801-810.